Showing results (861-870 of 927) with videos related to

Sort By:
Pageof 93
JCI Insight|February 22, 2024
The shifting lipidomic landscape of blood monocytes and neutrophils during pneumoniaAlex R Schuurman, Osoul Chouchane, Joe M Butler, et al.
The Journal of Infection|March 2, 2024
Lymphopenia is associated with broad host response aberrations in community-acquired pneumoniaSusanne E Doeleman, Tom D Y Reijnders, Sebastiaan C M Joosten, et al.
Ebiomedicine|June 12, 2025
Pathogen-specific host response in critically ill patients with blood stream infections: a nested case-control studyJoe M Butler, Hessel Peters-Sengers, Tom D Y Reijnders, et al.
The European Respiratory Journal|January 23, 2025
The blood transcriptional response in patients developing intensive care unit-acquired pneumoniaJustin de Brabander, Erik H A Michels, Joe M Butler, et al.
Plos One|November 24, 2011
Geriatric conditions in acutely hospitalized older patients: prevalence and one-year survival and functional declineBianca M Buurman, Jita G Hoogerduijn, Rob J de Haan, et al.
Critical Care Medicine|July 25, 2012
Transfusion-related acute lung injury in cardiac surgery patients is characterized by pulmonary inflammation and coagulopathy: a prospective nested case-control studyAlexander P J Vlaar, Jorrit J Hofstra, Rogier M Determann, et al.
American Journal of Respiratory and Critical Care Medicine|June 9, 2007
Prophylactic heparin in patients with severe sepsis treated with drotrecogin alfa (activated)Marcel Levi, Mitchell Levy, Mark D Williams, et al.
Circulation|November 13, 2002
Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteersNick R Bijsterveld, Arno H Moons, S Matthijs Boekholdt, et al.
British Journal of Haematology|July 19, 2006
Endotoxaemia induces resistance to activated protein C in healthy humansAnne-Cornélie J M de Pont, Kamran Bakhtiari, Barbara A Hutten, et al.
European Journal of Internal Medicine|November 9, 2020
Interleukin-6 receptor blockade with subcutaneous tocilizumab improves coagulation activity in patients with COVID-19Marcello Di Nisio, Nicola Potere, Matteo Candeloro, et al.
Pageof 93